Mark Bowlby, PhD, has over 25 years of experience in the clinical research and drug development industry. 在过去的 10 年中，他领导了许多新药申请、生物制品许可申请和向美国食品药品监督管理局和欧洲药品管理局提交的研究性新药 (IND) 申请。Mark has led the authoring of Investigator’s Brochures (IBs), clinical study reports (CSRs), clinical summaries and overviews, briefing packages, and other regulatory documents. Earlier in his career, Mark planned and wrote numerous biomedical manuscripts, posters, and slides regarding his scientific research and postdoctoral work at Harvard Medical School. 他的专业治疗领域包括眼科、神经病学、精神病学和慢性疼痛。Mark has an expert understanding of drug discovery and development approaches used in the current biopharmaceutical environment.